A recent study published in The Lancet highlights alarming cardiovascular risks for women diagnosed with polyendocrine metabolic ovarian syndrome (PMOS). This condition, affecting 10-13% of women of reproductive age, significantly increases the likelihood of heart disease, heart attacks, and strokes. Women with PMOS are 4.4 times more likely to develop heart disease and 3.5 times more likely to suffer a heart attack compared to those without the condition.
The implications of this research extend beyond reproductive health, indicating a pressing need for increased awareness and monitoring of cardiovascular health in women with PMOS. The study analysed data from over 2.4 million women, revealing that many remain undiagnosed, which could lead to serious health complications if left unaddressed.
Dr. Anuja Dokras, the study’s senior author, emphasised the importance of managing risk factors such as high blood pressure, cholesterol, and diabetes. This highlights a crucial shift in how PMOS is perceived, urging healthcare providers to adopt a more holistic approach to treatment.
As awareness grows, women with PMOS are encouraged to take proactive steps in managing their heart health. This includes lifestyle changes and regular health check-ups, which could significantly reduce their risk of severe cardiovascular events in the future.
Source: GB News
